FDA Pushes DSCSA Serialization Enforcement Deadline to 2018

Article

The agency has pushed back by one year the deadline for compliance with DSCSA serialization requirements.

On June 30, 2017, FDA published draft guidance on product identifiers and verification in connection with the US Drug Supply Chain Security Act (DSCSA). 

Noting the fact that some pharmaceutical manufacturers still have not installed the technologies required, and acknowledging the limited number of vendors capable of offering solutions, as well as lack of readiness among contract manufacturers, FDA is now giving pharma companies until Nov. 26, 2018 to meet requirements.

This year, a number of surveys had shown that a significant number of small-to-mid-sized pharma companies were still not ready for serialization requirements required by DSCSA and the Nov. 27, 2017 compliance deadline. This additional time should allow them more time to examine the scope of work required and evaluate the best solutions.

Source: FDA

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes